Recommended Antibiotic for Bacterial Gastroenteritis
Azithromycin is the first-line antibiotic for bacterial gastroenteritis when treatment is indicated, particularly for dysentery (bloody diarrhea) or severe cases with fever. 1, 2
When Antibiotics Are Actually Needed
Most gastroenteritis is viral and does not require antibiotics. 2 Antibiotic treatment should be reserved for:
- Dysentery (bloody diarrhea with fever) - Strong indication 1
- Severe watery diarrhea with high fever (>38.5°C) suggesting invasive bacterial disease 1
- Immunocompromised patients with moderate-to-severe symptoms 1
- Specific high-risk groups: infants <3 months, adults >50 years with atherosclerosis, patients with valvular heart disease or prosthetic vascular materials 1
First-Line Treatment: Azithromycin
Dosing:
- Adults: 500 mg once daily for 3 days OR 1 gram single dose 1, 2, 3
- Children: 10 mg/kg once daily for 3 days (maximum 500 mg/day) 1, 4
Why azithromycin is preferred:
- Superior efficacy against fluoroquinolone-resistant Campylobacter (>90% resistance rates in many regions) 1
- Effective against Shigella, Salmonella, enteroinvasive E. coli, Aeromonas, and Yersinia 1, 5
- Better tolerated than fluoroquinolones with fewer serious adverse effects 1
- No risk of C. difficile infection or tendon rupture (unlike fluoroquinolones) 1
- Single-dose regimen improves compliance 1, 2
Common side effects: Nausea (3%), vomiting (<1%), diarrhea (5.9%) - can be reduced by splitting the 1-gram dose over the first day 1, 3
Pathogen-Specific Recommendations
Campylobacter
- First choice: Azithromycin 500 mg daily × 3 days 1
- Alternative: Ciprofloxacin 500 mg twice daily × 3 days (only if local resistance <10%) 1
Shigella
- First choice: Azithromycin 500 mg daily × 3 days OR 1 gram single dose 1
- Alternative: Ceftriaxone 2 grams IV daily (if azithromycin unavailable) 1
- Avoid fluoroquinolones if ciprofloxacin MIC ≥0.12 μg/mL, even if reported as "susceptible" 1
Non-typhoidal Salmonella
- Usually no antibiotics needed for uncomplicated gastroenteritis (prolongs carrier state) 1
- Treat if: Age <3 months, >50 years with vascular disease, immunocompromised, or invasive disease 1
- If treating: Ceftriaxone 2 grams IV daily OR ciprofloxacin 500 mg twice daily × 5-7 days (if susceptible) 1
Vibrio cholerae
Yersinia enterocolitica
- First choice: Trimethoprim-sulfamethoxazole 160/800 mg twice daily × 5 days 1
- Alternative: Ciprofloxacin 500 mg twice daily × 5 days 1
Second-Line Options (When Azithromycin Cannot Be Used)
Ciprofloxacin
- Dosing: 500 mg twice daily × 3 days OR 750 mg single dose 1
- Use only if: Local Campylobacter fluoroquinolone resistance <10% AND patient has no risk factors for resistant organisms 1
- Major concerns: Widespread resistance in Campylobacter (>90% in Thailand, increasing globally), C. difficile risk, tendon rupture risk, QT prolongation 1
Rifaximin
- Dosing: 200 mg three times daily × 3 days 1
- Use only for: Non-invasive watery diarrhea (traveler's diarrhea from E. coli) 1
- Do NOT use for: Dysentery, fever, or suspected invasive pathogens (Campylobacter, Shigella, Salmonella) - failure rate up to 50% 1
Trimethoprim-Sulfamethoxazole
- Dosing: 160/800 mg twice daily × 3-5 days 1, 6
- Limited use due to: Widespread resistance in Shigella and Salmonella 1
- Consider for: Yersinia infections or when azithromycin/fluoroquinolones contraindicated 1
Critical Pitfalls to Avoid
Do not use fluoroquinolones empirically for dysentery - Resistance rates in Campylobacter and Shigella make them unreliable first-line agents 1
Do not use rifaximin for bloody diarrhea or fever - It fails in 50% of invasive infections 1
Do not treat uncomplicated non-typhoidal Salmonella gastroenteritis - Antibiotics prolong fecal shedding without clinical benefit 1
Do not rely on "susceptible" fluoroquinolone reports for Shigella if ciprofloxacin MIC ≥0.12 μg/mL - Clinical failures occur despite laboratory susceptibility 1
Always provide rehydration therapy - Antibiotics are adjunctive; fluid replacement is the cornerstone of treatment 2
Special Populations
Pregnant women: Azithromycin is safe; avoid doxycycline and fluoroquinolones 7, 2
Children: Azithromycin 10 mg/kg daily × 3 days; avoid fluoroquinolones in children <18 years due to cartilage toxicity 1, 4
Immunocompromised: Consider longer treatment courses (5-7 days) and broader coverage; may need ceftriaxone for severe disease 1, 2